Inpatient Consultative Dermatology and Severe Cutaneous Adverse Reactions
|
|
- Gwenda Spencer
- 6 years ago
- Views:
Transcription
1 Inpatient Consultative Dermatology and Severe Cutaneous Adverse Reactions Jeremy A. Schneider, MD Assistant Clinical Professor UC San Diego Department of Dermatology
2 Objectives Brief overview of some of the most severe dermatologic conditions encountered in the inpatient setting, with a focus on DRESS/DIHS and SJS/TEN Summarize the current data regarding the management of severe cutaneous adverse reactions
3 Nightmare Fuel* *not even close to comprehensive Infectious Necrotizing fasciitis Echthyma gangrenosum Purpura fulminans, meningoccocemia Rickettsial disease (e.g. RMSF) Toxic shock syndrome Drug reactions Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Drug-induced hypersensitivity syndrome (DIHS)/Drug reaction with eosinophilia and systemic symptoms (DRESS) Immune reactions Graft-versus-host disease Kawasaki disease (yes, even in adults) Malignancy Sezary syndrome/ctcl Erythroderma (any etiology)
4 Case 1 62 yo M with h/o PMR presented to OSH with sepsis, neutropenia started on cefepime and tobramycin; workup for neutropenia (including BMBx) revealed ALL. Transferred for further treatment and workup. Dermatology consulted for skin lesions x 2-3 weeks, began as red flat patches which then formed bullae filled with blood, then black patches with purple borders. No new lesions have developed since beginning antibiotics at OSH. All photos for this case courtesy of David Cotter, MD, PhD
5 Case 1
6 What would the best next step(s) be? A. Biopsy for H&E and tissue culture B. Collect blood cultures C. Begin broad spectrum antimicrobial treatment, including antipseudomonal agent D. Debride necrotic tissue E. Consult orthopedic surgery F. A and B G. B and C H. A, B, and C I. All of the above
7 Echthyma gangrenosum Presentation: painless red macules -> induration -> pustules and/or bullae -> gangrenous ulcers (rapid progression hours); most common sites: anogenital, axillary sites Pathophysiology: perivascular bacterial invasion of media and adventitia of arteries and veins, resulting in ischemic necrosis P. aeruginosa most common but other organisms described, including (but not limited to): P. stutzeri, Aeromonas spp, Stenotrophomonas spp, Citrobacter spp, MRSA, atypical mycobacteria, Fusarium spp, Candida spp
8 Echthyma gangrenosum Evaluation: Prompt collection of blood cultures Culture of exudates from aspirate or swab of lesions If above are negative, biopsy for tissue culture (bacterial, fungal, mycobacterial) can help exclude other etiologies Management Empiric antimicrobial coverage including agent with antipseudomonal activity; tailor to culture results Severe/extensive necrosis may require debridement +/- skin grafting
9 Case 2 42 yo M with HTN, IDDM2, gout presents to Dermatology clinic from PCP visit for rash. Initiated on allopurinol for gout 4 weeks PTA; 2 weeks PTA, developed bumps on face, then itchy pink-red rash on trunk. ROS notable for subjective fevers at home. Meds: HCTZ, lisinopril, metoprolol, spironolactone, saxagliptin, metformin, glargine, atorvastatin, allopurinol Exam: as depicted; also with facial swelling, diffuse lymphadenopathy All photos for this case courtesy of Keith Roby, MD
10
11 What would be the next best step(s)? A. Check CBC with manual diff B. Check CMP including LFTs C. Pulmonary imaging (CXR or CT chest) D. EKG and echocardiogram, serum troponins E. Check a thyroid panel F. Check a CK G. Start IVIG H. Start high dose systemic corticosteroids I. All of the above except G J. All of the above except H
12 Day 3
13 Drug-induced hypersensitivity syndrome AKA Drug reaction with eosinophilia and systemic symptoms (DRESS) Rash, fever, malaise, lymphadenopathy, facial edema, hematologic abnormalities (eosinophilia, atypical lymphocytes), lymphadenopathy, liver, kidney, and/or lung involvement Long latency between exposure and onset (2-8 weeks) Strong activation of drug-specific T cells (CD8, CD4 and T-regs); role of viral reactivation unclear (cause or effect?) but frequent (HHV-6, HHV-7, EBV, CMV)
14 Score Min Max Fever>/=38.5 C No/U Yes -1 0 Enlarged lymph nodes No/U Yes 0 1 Eosinophilia if leukocytes>4000 No/U /uL >/= 1500/uL 0 2 Eosinophilia if leukocytes < % >/= 20% 0 2 Atypical lymphocytes No/U Yes 0 1 Skin involvement -2 2 Rash >50% No/U Yes Rash suggesting DRESS No U Yes Biopsy suggesting DRESS No Yes/U Organ involvement 0 2 Liver No/U Yes Kidney No/U Yes Lung No/U Yes Muscle/heart No/U Yes Pancreas No/U Yes Other organ(s) No/U Yes Resolution >/=15 days No/U Yes -1 0 Evalutation other potential causes 0 1 ANA Blood culture Serology for HAV/HBV/HCV Chlamydia-/Mycoplasma pneumoniae Other serology/pcr If none positive and 3 or more negative TOTAL SCORE -4 9 <2: no case; 2-3: possible; 4-5: probable; >5: definite Yes Table adapted from Kardaun et al
15 DIHS/DRESS Management Withdrawal of offending drug (and any nonessential medications) Without systemic involvement or LFT elevation < 3 times ULN can treat symptoms with high or super high potency topical corticosteroids Patients with severe hepatitis should be promptly referred to hepatologist as may evolve to ALF requiring transplantation Severe interstitial nephritis or interstitial pneumonia, prednisone 0.5 to 2 mg/kg per day until clinical improvement/normalization of laboratory parameters; SLOW taper over 8-12 weeks
16 Case 3 66 yo F with multiple myeloma and NHL s/p R-CHOP x 6 cycles (completed 6 months PTA) and autologous SCT (1 month PTA) admitted for cough, nausea, decreased oral intake, and fever.started treatment for CT finding of atypical PNA v aspiration. Dermatology consulted for progressive rash 1 week into admission. Patient and family report that, since admission, developed conjunctival injection followed by peeling skin on chest, shoulders, and then upper thighs. No oral or genital mucosal involvement.
17
18 What is your next step? A. Create medication timeline and discontinue culprit and nonessential medications B. Check quantitative immunoglobulins and initiate IVIG therapy C. Start cyclosporine therapy D. Check quantiferon TB test and start TNF-alpha inhibitor E. Start high dose corticosteroids F. A and B G. A and C H. A and D I. A and E J. A and adjunctive therapy will depend on patient s comorbidities and relative/absolute contraindications to individual therapeutic options
19 Med timeline: Fluconazole (started 3 months prior to rash) Acyclovir (2.5 weeks prior to rash) Sulfamethoxazole-trimethoprim (2.5 weeks prior to rash) Azithromycin (3 weeks prior to rash) Vancomycin (1-3 days prior to rash) Cefepime (1-3 days prior to rash) Ciprofloxacin (1 month prior to rash) Moxifloxacin (started after rash)
20 Table from Schneider JA and Cohen PR. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures
21 Lessons learned Echthyma gangrenosum, while typically associated with Pseudomonas, can be caused by multiple other infectious agents Severity of erythema may be underestimated in skin of color DRESS/DIHS may progress to exfoliative and bullous lesions, which may create diagnostic confusion SCORTEN is most accurate on hospital days 1 and 3 Evidence-based management for severe cutaneous adverse reactions continues to evolve supportive care differs from that of burn patients with same BSA adjunctive therapy should be tailored based on patient s comorbidities/risk factors
22 Acknowledgements
23 References Chung WH, Hung SI, Yang JY, Su SC, Huang SP, Wei CY, Chin SW, Chiou CC, Chu SC, Ho HC, Yang CH, Lu CF, Wu JY, Liao YD, Chen YT. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med. 2008;14(12): Downey A, Jackson C, Harun N, Cooper A. Toxic epidermal necrolysis: review of pathogenesis and management. J Am Acad Dermatol. 2012;66: Guegan S, Bastuji-Garin S, Poszepczynska-Guigne E, Roujeau JC, Revuz J. Performance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysis. J Invest Dermatol. 2006;126(2): Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: Part I. Clinical perspectives. Journal of the American Academy of Dermatology May 31;68(5):693-e1. Hazin R, Ibrahimi OA, Hazin MI, Kimyai-Asadi A. Stevens-Johnson syndrome: pathogenesis diagnosis, and management. Ann Med. 2008;40: Huang YC, Li YC, Chen TJ. The efficacy of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis: a systematic review and meta-analysis. Br J Dermatol Aug;167(2): Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: Part II. Management and therapeutics. Journal of the American Academy of Dermatology May 31;68(5):709-e1. Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, Roujeau JC. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?. British Journal of Dermatology Mar 1;156(3): Kardaun SH, Mockenhaupt M, Roujeau JC. Comments on: DRESS syndrome. Journal of the American Academy of Dermatology Nov 1;71(5): Kirchhof MG, Miliszewski MA, Sikora S, Papp A, Dutz JP. Retrospective review of Stevens-Johnson syndrome/toxic epidermal necrolysis treatment comparing intravenous immunoglobulin with cyclosporine. J Am Acad Dermatol. 2014;71(5):941. Kumar P and Kanti Das, N. Cyclosporine in toxic epidermal necrolysis: a brief review of the emerging therapeutic modality. Dermatol Online J. 2016;22(10).
24 References (continued) Lee HY, Fook-Chong S, Koh HY, Thirumoorthy T, Pang SM. Cyclosporine treatment for Stevens-Johnson syndrome/toxic epidermal necrolysis: Retrospective analysis of a cohort treated in a specialized referral center. J Am Acad Dermatol Jan;76(1): Lee HY, Lim YL, Thirumoorthy T, Pang SM. The role of intravenous immunoglobulin in toxic epidermal necrolysis: a retrospective analysis of 64 patients managed in a specialized centre. Br J Dermatol Dec;169(6): Mayes T, Gottschlich M, Khoury J, Warner P, Kagan R. Energy requirements of pediatric patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. Nutr Clin Pract. 2008;23(5):547. Roujeau JC, Bastuji-Garin S. Systematic review of treatments for Stevens-Johnson syndrome and toxic epidermal necrolysis using the SCORTEN score as a tool for evaluating mortality. Ther Adv Drug Saf. 2011;2(3):87. Sassolas B, Haddad C, Mockenhaupt M, Dunant A, Liss Y, Bork K, Haustein UF, Vieluf D, Roujeau JC, Le Louet H. ALDEN, an algorithm for assessment of drug causality in Stevens Johnson syndrome and toxic epidermal necrolysis: comparison with case control analysis. Clinical Pharmacology&Therapeutics Jul 1;88(1):60-8. Schneck J, Fagot JP, Sekula P, Sassolas B, Roujeau JC, Mockenhaupt M. Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study. J Am Acad Dermatol. 2008;58(1):33. Schneider JA, Cohen PR. Stevens-Johnson syndrome and toxic epidermal necrolysis: a concise review with a comprehensive summary of therapeutic interventions emphasizing supportive measures. Advances in therapy Jun 1;34(6): Shiga S, Cartotto R. What are the fluid requirements in toxic epidermal necrolysis? J Burn Care Res. 2010;31(1): Valeyrie-Allanore L, Wolkenstein P, Brochard L, Ortonne N, Maître B, Revuz J, Bagot M, Roujeau JC. Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol. 2010;163(4):847. Wojtkiewicz A, Wysocki M, Fortuna J, Chrupek M, Matczuk M, Koltan A. Beneficial and rapid effect of infliximab on the course of toxic epidermal necrolysis. Acta Derm Venereol. 2008;88(4): Zárate-Correa LC, Carrillo-Gómez DC, Ramírez-Escobar AF, Serrano-Reyes C. Toxic epidermal necrolysis successfully treated with infliximab.
Warfarin-induced toxic epidermal necrolysis in combination therapy of Henoch- Schönlein purpura nephritis: a case report
Kasahara et al. BMC Nephrology (2017) 18:237 DOI 10.1186/s12882-017-0648-9 CASE REPORT Open Access Warfarin-induced toxic epidermal necrolysis in combination therapy of Henoch- Schönlein purpura nephritis:
More informationBugs and Drugs: What s New in Hypersensitivity Reactions?
Bugs and Drugs: What s New in Hypersensitivity Reactions? Erin Mathes, MD Associate Professor of Dermatology and Pediatrics University of California, San Francisco DISCLOSURE OF RELATIONSHIPS WITH INDUSTRY
More informationallergy Asia Pacific Stevens-Johnson syndrome and toxic epidermal necrolysis in Dr. Hasan Sadikin General Hospital Bandung, Indonesia from
pissn -876 eissn -868 Original Article Asia Pac Allergy 6;6:-7 Stevens-Johnson syndrome and toxic epidermal necrolysis in Dr. Hasan Sadikin General Hospital Bandung, Indonesia from 9 Oki Suwarsa *, Wulan
More informationScratching the Surface: A Review of SJS/TEN
Scratching the Surface: A Review of SJS/TEN Sarah Smith, PharmD Pharmacy Grand Rounds 2018 November 27, 2018 2018 MFMER slide 1 Toxic Epidermal Necrolysis Cutaneous Anthrax Stevens Johnson Syndrome Necrotizing
More informationEFAVIRENZ ASSOCIATED STEVENS-JOHNSON SYNDROME
EFAVIRENZ ASSOCIATED STEVENS-JOHNSON SYNDROME To the Editor: Persons with human immunodeficiency virus (HIV) infection are highly susceptible to adverse dermatological reactions to specific medications
More informationStevens-Johnson s Syndrome / Toxic Epidermal Necrolysis: An update
Stevens-Johnson s Syndrome / Toxic Epidermal Necrolysis: An update Robert G. Micheletti, MD Assistant Professor of Dermatology and Medicine Director, Cutaneous Vasculitis Clinic, Penn Vasculitis Center
More informationDrug-induced stevens-johnson syndrome : Experience from a tertiary care hospital
Original article: Drug-induced stevens-johnson syndrome : Experience from a tertiary care hospital *Arjun R 1,Mahalingeshwara Bhat K P 2, Sara C 1 1 PG student in General Medicine, KS Hegde Medical Acadamy,
More informationSkin Manifestations of Drug Reactions
Skin Manifestations of Drug Reactions Dr Carol Hlela, Division of Dermatology Department of Medicine, University of Cape Town and Red Cross Children s Hospital What are the Skin Manifestations of Drug
More informationCutaneous Conditions Associated with Systemic Disease
Cutaneous Conditions Associated with Systemic Disease Johnnie M Woodson, M.D., F.A.A.D. Assistant Professor of Dermatology University of Nevada School of Medicine Director of J. Woodson Dermatology & Associates,
More informationCorrespondence should be addressed to Wanjarus Roongpisuthipong; rr
Dermatology Research and Practice, Article ID 237821, 5 pages http://dx.doi.org/10.1155/2014/237821 Research Article Retrospective Analysis of Corticosteroid Treatment in Stevens-Johnson Syndrome and/or
More informationABSTRACT. Keywords: Corticosteroids; Cyclosporine; Dermatology; Etanercept; Immunoglobulin; Necrolysis; Johnson; Stevens; Syndrome REVIEW
Adv Ther (2017) 34:1235 1244 DOI 10.1007/s12325-017-0530-y REVIEW Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing
More informationREGISTRY OF SEVERE CUTANEOUS ADVERSE REACTIONS TO DRUGS AND COLLECTION OF BIOLOGICAL SAMPLES. R e g i S C A R PATIENT'S DATA. Age country of birth
REGISTRY OF SEVERE CUTANEOUS ADVERSE REACTIONS TO DRUGS AND COLLECTION OF BIOLOGICAL SAMPLES R e g i S C A R PATIENT'S DATA Initials of the patient date of birth Age country of birth Gender male female
More informationStevens Johnson Syndrome: How Diagnosis Impacts Disease Course
Southern Adventist Univeristy KnowledgeExchange@Southern Graduate Research Projects Nursing 12-4-2015 Stevens Johnson Syndrome: How Diagnosis Impacts Disease Course Sharon K. Hart Southern Adventist University,
More informationFuture of Pediatrics: Blisters, Hives and Other Tales from the Emergency Room June 14 th, 2016
A. Yasmine Kirkorian MD Assistant Professor of Dermatology & Pediatrics Children s National Health System George Washington University School of Medicine & Health Sciences Future of Pediatrics: Blisters,
More informationBig rashes in little patients:
! Big rashes in little patients: Severe drug eruptions and cutaneous infections!! Marcia Hogeling, MD, FAAD Assistant Clinical Professor Director, Pediatric Dermatology Division of Dermatology David Geffen
More informationPneumonia Community-Acquired Healthcare-Associated
Pneumonia Community-Acquired Healthcare-Associated Edwin Yu Clin Infect Dis 2007;44(S2):27-72 Am J Respir Crit Care Med 2005; 171:388-416 IDSA / ATS Guidelines Microbiology Principles and Practice of Infectious
More informationTo update the use of IVIG and CORTICOIDS IN management of SJS/ TEN To remind Doctors being careful when giving
Present : Dr Pham Thi Minh Rang Internal Department No2-Hospital for children No2 AIMS To update the use of IVIG and CORTICOIDS IN management of SJS/ TEN To remind Doctors being careful when giving To
More informationOXCARBAZEPINE-INDUCED STEVENS-JOHNSON SYNDROME: A CASE REPORT
OXCARBAZEPINE-INDUCED STEVENS-JOHNSON SYNDROME: A CASE REPORT Lung-Chang Lin, 1,2 Ping-Chin Lai, 3 Sheau-Fang Yang, 4 and Rei-Cheng Yang 1,5 Departments of 1 Pediatrics and 4 Pathology, Kaohsiung Medical
More informationA Case Report on Amoxicillin Induced Stevens- Johnson Syndrome
Open Journal of Clinical & Medical Case Reports Volume 2 (2016) Issue 11 A Case Report on Amoxicillin Induced Stevens- Johnson Syndrome Rajendra Singh Airee*; Aastha Rawal; Binu Mathew; H. Doddayya Abstract
More informationSevere Cutaneous Adverse Reactions Related to Systemic Antibiotics
MAJOR ARTICLE Severe Cutaneous Adverse Reactions Related to Systemic Antibiotics Ying-Fang Lin, 1 Chih-Hsun Yang, 2,3 Hu Sindy, 1,3 Jing-Yi Lin, 2,3 Chung-Yee Rosaline Hui, 2,3 Yun-Chen Tsai, 2 Ting-Shu
More informationBJD. Summary. British Journal of Dermatology THERAPEUTICS
THERAPEUTICS BJD British Journal of Dermatology Drug reaction with eosinophilia and systemic symptoms: is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of
More informationStevens-Johnson syndrome (SJS) and toxic epidermal. necrolysis in Asian children
Stevens-Johnson syndrome and toxic epidermal necrolysis in Asian children Mark Jean-Aan Koh, MD, and Yong-Kwang Tay, MD Singapore Background: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis
More informationDecember 3, 2015 Severe Sepsis and Septic Shock Antibiotic Guide
Severe Sepsis and Septic Shock Antibiotic Guide Surviving Sepsis: The choice of empirical antimicrobial therapy depends on complex issues related to the patient s history, including drug intolerances,
More informationPediatric Dermatology
Pediatric Dermatology --------- Emergencies & Urgencies Nicholas V. Nguyen, M.D. Director, Pediatric Dermatology Disclosures In the past 12 months, I have had the following financial relationships with
More informationDERMATOLOGIC EMERGENCIES. Mary Evers D.O., F.A.O.C.D. Georgetown, Texas
DERMATOLOGIC EMERGENCIES Mary Evers D.O., F.A.O.C.D. Georgetown, Texas SKIN EMERGENCIES??? Subclassifications: Autoimmune (Anaphylaxis, Vasculitis, Pemphigus) Erythroderma (AGEP, DRESS, SJS, TEN) Infectious
More informationSTEVEN JOHNSON S SYNDROME: A BRIEF REVIEW
STEVEN JOHNSON S SYNDROME: A BRIEF REVIEW G. Ramya sree*, Sreeram Vandavasi Guru 1, E. Sam Jeeva Kumar 2 * Pharm D, Intern, P. Rami Reddy Memorial College of Pharmacy, Kadapa. 1 Pharm-D Intern, P. Rami
More informationCARBAMAZEPINE INDUCED STEVENS JOHNSON SYNDROME- A CASE STUDY
WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES Ragesh SJIF Impact Factor 2.786 Volume 3, Issue 6, 1599-1604. Case Study ISSN 2278 4357 CARBAMAZEPINE INDUCED STEVENS JOHNSON SYNDROME- A CASE STUDY
More informationHIV-Associated Toxic Epidermal Necrolysis at San Francisco General Hospital: A 13-Year Retrospective Review
HIV Clinical Management HIV-Associated Toxic Epidermal Necrolysis at San Francisco General Hospital: A 13-Year Retrospective Review Journal of the International Association of Providers of AIDS Care 2017,
More informationSKIN REACTIONS WITH PSYCHOTROPICS: A SYSTEMATIC REVIEW
SKIN REACTIONS WITH PSYCHOTROPICS: A SYSTEMATIC REVIEW *Anderson Isaac, PharmD Candidate, 2019 Pooja Patel, PharmD Candidate, 2019 Katelyn Thomasson, PharmD Candidate, 2019 Erika Tillery, PharmD, BCPP,
More informationSJS/TEN spectrum. Stevens-Johnson syndrome (SJS) /Toxic Epidermal Necrolysis (TEN) 10/7/2016
Jesse Keller MD Assistant Professor Oregon Health & Science University Stevens-Johnson syndrome (SJS) /Toxic Epidermal Necrolysis (TEN) Drug induced dermemergencies that exist on a spectrum Delayed reaction:
More informationRisk Factors and Management of Mood Stabilizer-associated Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Mini-review
140 Taiwanese Journal of Psychiatry (Taipei) Vol. 25 No. 3 2011 Overview Risk Factors and Management of Mood Stabilizer-associated Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Mini-review Gen-Tang
More informationFive things not to miss in Dermatology. Dr Judy Wismer Associate Clinical Professor Michael G DeGroote School of Medicine
Five things not to miss in Dermatology Dr Judy Wismer Associate Clinical Professor Michael G DeGroote School of Medicine Key Descriptives Fever, skin pain Purpura, necrosis Bullae, Mucosal, Skin sloughing
More informationCase 1. Debridement Cultures Keflex Silvadene
The Red Breast Beth McLellan, M.D. Assistant Professor Division of Dermatology Albert Einstein College of Medicine Montefiore Medical Center Jacobi Medical Center Case 1 48 year old radiation oncologist
More informationClinicopathologic Self-Assessment
Clinicopathologic Self-Assessment Handout Symposium (S003), July 27 th 2017 Maija Kiuru MD PhD Assistant Professor, Departments of Dermatology & Pathology University of California Davis CASE 1: History
More informationClinical Manifestations of HIV
HIV Symptoms Diane Havlir, MD Professor of Medicine and Chief, HIV/AIDS Division University of California, San Francisco (UCSF) WorldMedSchool; July 2, 2013 1 Clinical Manifestations of HIV! Result from
More informationReview Article Treatments for Severe Cutaneous Adverse Reactions
Hindawi Journal of Immunology Research Volume 2017, Article ID 1503709, 9 pages https://doi.org/10.1155/2017/1503709 Review Article Treatments for Severe Cutaneous Adverse Reactions Yung-Tsu Cho and Chia-Yu
More informationDERMATOLOGICAL EMERGENCIES. DR. Ian Hoyle MBBS DIP IMC RCS (Ed), DA (UK),FRACGP,FACRRM,DIP DERM(Wales) TASMANIAN SKIN AND BODY CENTRE
DERMATOLOGICAL EMERGENCIES DR. Ian Hoyle MBBS DIP IMC RCS (Ed), DA (UK),FRACGP,FACRRM,DIP DERM(Wales) TASMANIAN SKIN AND BODY CENTRE Dermatological Emergencies INFECTIONS ERYTHRODERMA DRUG ERUPTIONS STEVENS-JOHNSON
More informationD.R.E.S.S. Syndrome An update. David H. Peng MD MPH Department of Dermatology Keck School of Medicine of USC
D.R.E.S.S. Syndrome An update David H. Peng MD MPH Department of Dermatology Keck School of Medicine of USC I have no disclosures I will be discussing off label uses for medications Maculopapular Morbilliform
More informationEmergency Dermatology Dr Melissa Barkham
Emergency Dermatology Dr Melissa Barkham Spotlight Seminar 30 th September 2010 Why is this important? Urgent recognition and treatment of dermatologic emergencies can be life saving and prevent long term
More informationUniversity of Groningen
University of Groningen Toxic epidermal necrolysis, DRESS, AGEP Bouvresse, Sophie; Valeyrie-Allanore, Laurence; Ortonne, Nicolas; Konstantinou, Marie Pauline; Kardaun, Sylvia H.; Bagot, Martine; Wolkenstein,
More informationFever in Lupus. 21 st April 2014
Fever in Lupus 21 st April 2014 Fever in lupus Cause of fever N= 487 % SLE fever 206 42 Infection in SLE 265 54.5 Active SLE and infection 8 1.6 Tumor fever 4 0.8 Miscellaneous 4 0.8 Crucial Question Infection
More informationDrug Allergy A Guide to Diagnosis and Management
Drug Allergy A Guide to Diagnosis and Management (Version 1 April 2015 updated April 2018) Author: Jed Hewitt Chief Pharmacist, Governance & Professional Practice Date of Preparation: April 2015 Updated:
More informationCASE REPORT. Narin Sriratanaviriyakul 1,2,3*, Lam-Phuong Nguyen 1,2,3, Mark C Henderson 2 and Timothy E Albertson 1,2,3
Sriratanaviriyakul et al. Journal of Medical Case Reports 2014, 8:332 JOURNAL OF MEDICAL CASE REPORTS CASE REPORT Open Access Drug reaction with eosinophilia and systemic symptoms syndrome (DRESS) syndrome
More informationPedsCases Podcast Scripts
PedsCases Podcast Scripts This is a text version of a podcast from Pedscases.com on Drug Allergy. These podcasts are designed to give medical students an overview of key topics in pediatrics. The audio
More informationSuperficial Granulomatous Pyoderma of the Face: A Case Report and Review of the Literature
Superficial Granulomatous Pyoderma of the Face: A Case Report and Review of the Literature Sarah M. Persing, MPH, a and Donald Laub Jr, MD, FACS a,b a University of Vermont College of Medicine, Burlington;
More informationSTEVENS-JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS IN CHILDREN: A LITERATURE REVIEW OF CURRENT TREATMENTS
STEVENS-JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS IN CHILDREN: A LITERATURE REVIEW OF CURRENT TREATMENTS *Blanca R. Del Pozzo-Magaña, 1 Alejandro Lazo-Langner 2,3 1. Department of Pediatrics, University
More informationManagement of Pyoderma Gangrenosum Mentoring in IBD XVII
Management of Pyoderma Gangrenosum Mentoring in IBD XVII Scott Walsh MD PhD FRCPC Division of Dermatology Sunnybrook Health Sciences Centre University of Toronto Pyoderma Gangrenosum: A pathological
More informationTreatment of febrile neutropenia in patients with neoplasia
Treatment of febrile neutropenia in patients with neoplasia George Samonis MD, PhD Medical Oncologist Infectious Diseases Specialist Professor of Medicine The University of Crete, Heraklion,, Crete, Greece
More informationCPC. Chutika Srisuttiyakorn, M.D. Kobkul Aunhachoke, M.D. Phramongkutklao Hospital Bangkok, Thailand
CPC Chutika Srisuttiyakorn, M.D. Kobkul Aunhachoke, M.D. Phramongkutklao Hospital Bangkok, Thailand A 53 year-old woman with fever, facial swelling and rashes on face, trunk and upper extremities for 3
More informationMark A. Bechtel, MD Clinical Associate Professor Division Director, Dermatology Ohio State University Medical Center
Dermatologic Emergencies Mark A. Bechtel, MD Clinical Associate Professor Division Director, Dermatology Ohio State University Medical Center Clinical Features of SJS/TEN Initial symptoms Fever, stinging
More informationEmergency Dermatology. Emergency Dermatology
Emergency Dermatology These are rapidly progressive skin conditions and some are potentially lifethreatening. Early recognition is important to implement prompt supportive care and therapy. Some are drug
More informationCase 1. Background. Presenting Symptoms. Schecter Case1 Differential Diagnosis of TB 1
TB or Not TB? Case 1 Gisela Schecter, M.D., M.P.H. California Department of Public Health Background 26 year old African American male Born and raised in Bay Area of California Convicted of cocaine trafficking
More informationTumor Necrosis Factor α Inhibitors in the Treatment of Toxic Epidermal Necrolysis
ORIGINAL RESEARCH Tumor Necrosis Factor α Inhibitors in the Treatment of Toxic Epidermal Necrolysis Katelyn F. Woolridge, MD; Patrick L. Boler, MD, PharmD; Brian D. Lee, MD PRACTICE POINTS Controversy
More informationSofosbuvir is an imperative drug used for the. Sofosbuvir Induced Steven Johnson Syndrome in a Patient With Hepatitis C Virus-Related Cirrhosis
HEPATOLOGY COMMUNICATIONS, VOL. 2, NO. 1, 2018 Sofosbuvir Induced Steven Johnson Syndrome in a Patient With Hepatitis C Virus-Related Cirrhosis Nipun Verma, 1 Shreya Singh, 2 Gitesh Sawatkar, 3 and Virendra
More informationCase Report Cephazolin-Induced Toxic Epidermal Necrolysis Treated with Intravenous Immunoglobulin and N-Acetylcysteine
Case Reports in Immunology Volume 2012, Article ID 931528, 4 pages doi:10.1155/2012/931528 Case Report Cephazolin-Induced Toxic Epidermal Necrolysis Treated with Intravenous Immunoglobulin and N-Acetylcysteine
More informationSkin Pathway Group Alemtuzumab in Cutaneous Lymphoma
Skin Pathway Group Alemtuzumab in Cutaneous Lymphoma Indication: Treatment of patients with Cutaneous Lymphoma (Unlicensed use) Disease control prior to Reduced Intensity Conditioning Stem Cell Transplant
More informationDr. Venkateswari. R. Dr. Janani Sankar s unit Kanchi Kamakoti CHILDS Trust Hospital
Dr. Venkateswari. R. Dr. Janani Sankar s unit Kanchi Kamakoti CHILDS Trust Hospital Acknowledgements: KKCTH Dr. Ramkumar Consultant Dermatologist Dr. Ramprakash Consultant Ophthalmologist Dr. Prasad Manne
More informationA Retrospective Study of Spectrum of Nevirapine Induced Cutaneous Drug Reactions in HIV Positive Patients
Journal of US-China Medical Science 12 (2015) 85-89 doi: 10.17265/1548-6648/2015.02.008 D DAVID PUBLISHING A Retrospective Study of Spectrum of Nevirapine Induced Cutaneous Drug Reactions in HIV Positive
More informationSEPTIC ARTHRITIS. Dr Ahmed Husam Al Ahmed Rheumatologist SYRIA. University of Science and technology Hospital Sanaa Yemen 18/Dec/2014
SEPTIC ARTHRITIS Dr Ahmed Husam Al Ahmed Rheumatologist SYRIA University of Science and technology Hospital Sanaa Yemen 18/Dec/2014 Objectives be able to define Septic Arthritis know what factors predispose
More informationDepartment of Dermatology, Christian Medical College and Hospital, Ludhiana, Punjab, India.
Bullous pemphigoid mimicking granulomatous inflammation Abhilasha Williams, Emy Abi Thomas. Department of Dermatology, Christian Medical College and Hospital, Ludhiana, Punjab, India. Egyptian Dermatology
More informationSevere β-lactam allergy. Alternative (use for mild-moderate β-lactam allergy) therapy
Recommended Empirical Antibiotic Regimens for MICU Patients Notes: The antibiotic regimens shown are general guidelines and should not replace clinical judgment. Always assess for antibiotic allergies.
More informationMelanoma Immunotherapy. Nursing Perspective on Immune-Related Adverse Events: Patient education, Monitoring & Management
Melanoma Immunotherapy Nursing Perspective on Immune-Related Adverse Events: Patient education, Monitoring & Management Mike Buljan, NP UCSF Medical Center Melanoma Oncology Disclosures None Only FDA-approved
More informationHow do we define pneumonia?
Robert L. Keith MD FCCP Associate Professor of Medicine Division of Pulmonary Sciences & Critical Care Medicine Denver VA Medical Center University of Colorado Denver How do we define pneumonia? Fever
More informationCauses and Treatment Outcomes of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in 82 Adult Patients
original article korean j intern med 2012;27:203-210 pissn 1226-3303 eissn 2005-6648 Causes and Treatment Outcomes of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in 82 Adult Patients Hye-In
More informationA Practical Approach to Leukopenia/Neutropenia in Children. Vandy Black, M.D., M.Sc., FAAP OLOL Children s Hospital August 24, 2014
A Practical Approach to Leukopenia/Neutropenia in Children Vandy Black, M.D., M.Sc., FAAP OLOL Children s Hospital August 24, 2014 Disclosures EPIC trial MAST Therapeutics SUSTAIN trial Selexys Pharmaceuticals
More informationA. Erythema multiforme and related diseases
Go Back to the Top To Order, Visit the Purchasing Page for Details Chapter Erythema, Erythroderma (Exfoliative Dermatitis) Erythema is caused by telangiectasia or hyperemia in the papillary and reticular
More informationDAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES
DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health
More information-> Education -> Excellence
Quality Conference 5/2557 Extravasations: Event -> Education -> Excellence รศ.นพ. รว ศ เร องตระก ล สาขาว ชาก มารศ ลยศาสตร ภาควชาศลยศาสตร Extravasations: Event 1. Thrombophlebitis - superficial vein 2.
More informationSevere cutaneous adverse reactions (SCAR) are life-threatening
Stevens-Johnson syndrome and toxic epidermal necrolysis: clinical patterns, diagnostic considerations, etiology, and therapeutic management Maja Mockenhaupt, MD, PhD n Abstract Severe cutaneous adverse
More informationTHE TIP OF THE ICEBERG SAMER BOLIS, DO PGY-3 LEHIGH VALLEY HEALTH NETWORK, ALLENTOWN PA
THE TIP OF THE ICEBERG SAMER BOLIS, DO PGY-3 LEHIGH VALLEY HEALTH NETWORK, ALLENTOWN PA Case The patient is a 48 year-old female, who recently returned from a trip to Puerto Rico. She presents to the ED
More informationID Emergencies. BGSMC Internal Medicine Edwin Yu
ID Emergencies BGSMC Internal Medicine Edwin Yu Learning Objectives Bacterial meningitis IDSA guidelines: Clin Infect Dis 2004; 39:1267-84 HSV encephalitis IDSA guidelines: Clin Infect Dis 2008; 47:303-27
More information1 Introduction. Kenneth Irungu 1 David Nyamu
Drugs - Real World Outcomes (2017) 4:79 85 DOI 10.1007/s40801-017-0105-x ORIGINAL RESEARCH ARTICLE Characterization of Stevens Johnson Syndrome and Toxic Epidermal Necrolysis Among Patients Admitted to
More informationTreatment of Coccidioidomycosis-associated Eosinophilic Pneumonia with Corticosteroids
Treatment of Coccidioidomycosis-associated Eosinophilic Pneumonia with Corticosteroids Joshua Malo, MD Yuval Raz, MD Linda Snyder, MD Kenneth Knox, MD University of Arizona Medical Center Department of
More informationDAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES
DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health
More informationGoals of this talk. Morbilliform. Common Morphologies in the Hospital 11/7/2017. Hospital Based Dermatology: Common and Tough Consult Cases
Hospital Based Dermatology: Common and Tough Consult Cases Lindy P. Fox MD Associate Professor of Clinical Dermatology Director, Hospital Consultation Service University of California, San Francisco lindy.fox@ucsf.edu
More informationOPTIMAL MANAGEMENT OF IMMUNE- RELATED ADVERSE EVENTS ASSOCIATED WITH CHECKPOINT INHIBITORS
OPTIMAL MANAGEMENT OF IMMUNE- RELATED ADVERSE EVENTS ASSOCIATED WITH CHECKPOINT INHIBITORS Alberto Fusi Charité Comprehensive Cancer Centre Berlin, Germany 1 Immune check point blockade with CTLA-4, anti-pd-1
More informationIn the past few years, beta-lactam-resistant gram-positive
Early Diagnosis Is Key in Vancomycin-Induced Linear IgA Bullous Dermatosis and Stevens-Johnson Syndrome Douglas H. Jones, MS Michael Todd, MD Timothy J. Craig, DO Background: With the emergence of highly
More informationAgenda* The 9th International Congress on Cutaneous Adverse Drug Reactions (iscar 2015)
1 of 5 Agenda* The 9th International Congress on Cutaneous Adverse Drug Reactions (iscar 2015) Co-chairs: Dr. Neil H. Shear at the 23rd World Congress of Dermatology in Vancouver, Canada. Division of Dermatology,
More informationCommunity Acquired & Nosocomial Pneumonias
Community Acquired & Nosocomial Pneumonias IDSA/ATS 2007 & 2016 Guidelines José Luis González, MD Clinical Assistant Professor of Medicine Outline Intro - Definitions & Diagnosing CAP treatment VAP & HAP
More informationAn Evidenced-Based Approach to the Adult with a Morbilliform Eruption
Relatively An Evidenced-Based Approach to the Adult with a Morbilliform Eruption Ben Kaffenberger, MD Assistant Professor, Dermatology Director, Inpatient Dermatology Consult Service Ohio State University
More informationAOU Ospedali Riuniti - Ancona
AOU Ospedali Riuniti - Ancona Ospedale Materno-Infantile di Alta Specializzazione G. Salesi UOC Pediatria Allergia a farmaci e infezioni: tra coesistenza e casualità fabrizio franceschini Drug Hypersensitivity
More informationToxic Epidermal Necrolysis - A Case Report
The Journal of Critical Care Medicine 2017;3(1):29-33 CASE REPORT Toxic Epidermal Necrolysis - A Case Report Laura Stătescu¹, Magda Constantin², Horia Silviu Morariu³ *, Laura Gheucă Solovăstru¹ ¹ Dermatology
More informationHerbal and homeopathic products, often considered natural and non-toxic, can also cause adverse drug reactions.
Idiosyncratic and potentially serious cutaneous adverse drug reactions (CADRs), although relatively rare, account for significant morbidity and mortality. RANNAKOE J LEHLOENYA, BSc, MB ChB, FCDerm (SA)
More informationCase Rep Dermatol 2009;1:66 70 DOI: / Key Words Coma Blister Barbiturate Overdose Meningoencephalitis
66 Coma Blisters Joana Rocha a Teresa Pereira a Filipa Ventura a Fernando Pardal b Celeste Brito a Departments of a Dermatology and b Pathology, Hospital de São Marcos, Braga, Portugal Key Words Coma Blister
More informationThe X factor in a blue moon. Monique Lee Campbelltown Hospital
The X factor in a blue moon Monique Lee Campbelltown Hospital Mrs MD 73 year old Increasing dyspnoea, hypoxia Recurrent lower respiratory tract infections Two hospital admissions parenteral antibiotics
More information3/25/2012. numerous micro-organismsorganisms
Congenital & Neonatal TB A Case of Tuberculosis Congenital or Acquired? Felicia Dworkin, MD NYC DOHMH Bureau TB Control World TB Day March 23, 2012 Congenital TB: acquired by the fetus during pregnancy
More informationThe Pulmonary Pathology of Iatrogenic Immunosuppression. Kevin O. Leslie, M.D. Mayo Clinic Scottsdale
The Pulmonary Pathology of Iatrogenic Immunosuppression Kevin O. Leslie, M.D. Mayo Clinic Scottsdale The indications for iatrogenic immunosuppression Autoimmune/inflammatory disease Chemotherapy for malignant
More informationAntibiotic Stewardship for Skin and Soft Tissue Infection and Respiratory Tract Infections
Antibiotic Stewardship for Skin and Soft Tissue Infection and Respiratory Tract Infections Ghinwa Dumyati, MD Professor of Medicine Center for Community Health and Infectious Diseases Division University
More informationVasculitis local: systemic
Vasculitis Inflammation of the vessel wall. Signs and symptoms: 1- local: according to the involved tissue 2- systemic:(fever, myalgia, arthralgias, and malaise) Pathogenesis 1- immune-mediated 2- infectious
More information11/19/2012. The spectrum of pulmonary diseases in HIV-infected persons is broad.
The spectrum of pulmonary diseases in HIV-infected persons is broad. HIV-associated Opportunistic infections Neoplasms Miscellaneous conditions Non HIV-associated Antiretroviral therapy (ART)-associated
More informationMantle-Cell Leukemia: Lessons in Life and Death
Mantle-Cell Leukemia: Lessons in Life and Death James J. Stark, MD, FACP Medical Director, Cancer Program and Palliative Care Maryview Medical Center Professor of Medicine, EVMS Case Presentation 60 y.o.
More informationSarcoidosis Case. Robert P. Baughman Interstitial Lung Disease and Sarcoidosis Clinic University of Cincinnati, USA. WASOG: educational material
Sarcoidosis Case Robert P. Baughman Interstitial Lung Disease and Sarcoidosis Clinic University of Cincinnati, USA WASOG: educational material Sarcoidosis Case patient is a Caucasian male age 46 was diagnosed
More informationClinical Aspect and Application of Laboratory Test in Herpes Virus Infection. Masoud Mardani M.D,FIDSA
Clinical Aspect and Application of Laboratory Test in Herpes Virus Infection Masoud Mardani M.D,FIDSA Shahidhid Bh BeheshtiMdi Medical lui Universityit Cytomegalovirus (CMV), Epstein Barr Virus(EBV), Herpes
More informationNeutropenic Fever 1 InpatientPediatric Treatment
Neutropenic Fever InpatientPediatric Treatment (Hematologic Cancers and Stem Cell Patients) te: This algorithm should not be used for patients receiving CAR cell therapy. Page of 8 Patient presents with
More informationID Emergencies. BUMC-P Internal Medicine Edwin Yu
ID Emergencies BUMC-P Internal Medicine Edwin Yu Learning Objectives Bacterial meningitis IDSA guidelines: Clin Infect Dis 2004; 39:1267-84 HSV encephalitis IDSA guidelines: Clin Infect Dis 2008; 47:303-27
More informationACUTE KIDNEY INJURY A PRIMER FOR PRIMARY CARE PHYSICIANS. Myriam Farah, MD, FRCPC
ACUTE KIDNEY INJURY A PRIMER FOR PRIMARY CARE PHYSICIANS Myriam Farah, MD, FRCPC Clinical Assistant Professor Division of Nephrology, University of British Columbia November 2016 1. How to recognize acute
More informationBrice Taylor Assistant Professor Division of Pulmonary and Critical Care Medicine
Brice Taylor Assistant Professor Division of Pulmonary and Critical Care Medicine Discuss advances in predicting prognosis Understand dwhat we know (and don t know) about the Microbiology Recognize important
More informationFever. National Pediatric Nighttime Curriculum Written by Debbie Sakai, M.D. Institution: Lucile Packard Children s Hospital
Fever National Pediatric Nighttime Curriculum Written by Debbie Sakai, M.D. Institution: Lucile Packard Children s Hospital Case 1 4-month-old well-appearing girl admitted for croup and respiratory distress.
More informationApproach to the Transplant Patient. Amy Musiek, MD AAD Annual Meeting 2018
Approach to the Transplant Patient Amy Musiek, MD AAD Annual Meeting 2018 Disclosures Actelion: speaker, advisory board, investigator Elorac: investigator Kyowa: investigator, advisory board Seattle genetics:
More informationMyositis and Your Lungs
Myositis and Your Lungs 2013 TMA Annual Patient Meeting Louisville, Kentucky Chester V. Oddis, MD University of Pittsburgh Director, Myositis Center Myositis Heterogeneous group of autoimmune syndromes
More information